<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094366</url>
  </required_header>
  <id_info>
    <org_study_id>OHSU IRB 6071</org_study_id>
    <nct_id>NCT01094366</nct_id>
  </id_info>
  <brief_title>Paracervical Block for Pain Control in First Trimester Abortion</brief_title>
  <official_title>An Evaluation of the Paracervical Block for Pain Control in First Trimester Surgical Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Planned Parenthood Federation of America</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many woman undergoing a surgical abortion receive a paracervical nerve block for pain
      reduction, in which lidocaine (a numbing medication) is injected around the cervix. These
      injections numb the cervix and possibly the lower part of the uterus. However, the injection
      can be uncomfortable and it is not well known whether it is effective in reducing pain. The
      purpose of this study is to determine the level of pain women experience with a surgical
      abortion and the effect that paracervical block might have on that pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators expect to have 120 women complete this study, between study sites at OHSU's
      Center for Women's Health and Planned Parenthood Columbia Willamette in Portland, OR. Every
      participant will still receive the standard oral medication for pain (ibuprofen) and anxiety
      (lorazepam). Eligible subjects will be at least 18 years of age, less than 11 weeks pregnant
      and have already decided to have a surgical abortion.

      The primary outcome evaluated will be pain reported at time of cervical dilation. The
      investigators will assess pain at various time points (including secondary outcomes)
      immediately upon completion of the respective step and pain and satisfaction 30 minutes
      postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reported with cervical dilation</measure>
    <time_frame>1 Year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded at time of cervical dilation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anticipated and reported pain at various time points</measure>
    <time_frame>1 Year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of anticipated pain) recorded prior to the procedure.
Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded at time of positioning for procedure, speculum insertion, placement of the PCB, aspiration and 30 min postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety reported with the pain expected during the procedure and the procedure itself.</measure>
    <time_frame>1 Year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting degree of anxiety) recorded prior to procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction reported with pain control and overall procedure</measure>
    <time_frame>1 Year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting degree of satisfaction) recorded post procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for additional intraoperative and/or postoperative pain medication</measure>
    <time_frame>1 Year</time_frame>
    <description>Subjects may request additional pain medication once their procedure has begun or in recovery. The need for additional medication, and what medication was subsequently distributed, will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Legal Abortion With Complication</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>No Paracervical Block for Pain Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subject will not receive a paracervical block during the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracervical Block for Pain Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will receive a paracervical block during the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Paracervical Block</intervention_name>
    <description>Subject receives 20 mL paracervical block with 18 mL of 1% Lidocaine solution buffered with 2 mL 8.4% sodium bicarbonate for pain control.</description>
    <arm_group_label>Paracervical Block for Pain Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham Paracervical Block</intervention_name>
    <description>In the non-intervention group, the surgeon performs a sham PCB during which 2 mL buffered lidocaine solution are injected at the tenaculum site, after which a capped needle gently simulates the standard PCB procedure.</description>
    <arm_group_label>No Paracervical Block for Pain Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 years or older

          -  Voluntarily requesting pregnancy termination

          -  Ultrasound confirmed intrauterine pregnancy up to 10 6/7 weeks gestational age

          -  Good general health

          -  English or Spanish speaking

          -  Be able and willing to sign an informed consent and agree to terms of the study

        Exclusion Criteria:

          -  Gestational ages over 11 0/7 weeks, due to routine misoprostol use at our institutions

          -  Incomplete abortion

          -  Required or requested narcotics or IV sedation (prior to randomization)

          -  Patients who refuse Ibuprofen and paracervical blocks

          -  Contraindications or allergies to lidocaine, ibuprofen or ativan

          -  Significant physical or mental health condition

          -  Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease

          -  Patients with known hepatic disease

          -  Women, who in the opinion of the investigator are not suitable for the study protocol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Regina M Renner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood Columbia Willamette</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Allen RH, Kumar D, Fitzmaurice G, Lifford KL, Goldberg AB. Pain management of first-trimester surgical abortion: effects of selection of local anesthesia with and without lorazepam or intravenous sedation. Contraception. 2006 Nov;74(5):407-13. Epub 2006 Aug 2.</citation>
    <PMID>17046383</PMID>
  </reference>
  <reference>
    <citation>BÃ©langer E, Melzack R, Lauzon P. Pain of first-trimester abortion: a study of psychosocial and medical predictors. Pain. 1989 Mar;36(3):339-50.</citation>
    <PMID>2710563</PMID>
  </reference>
  <reference>
    <citation>Berger GS, Tyler CW, Harrod EK. Maternal deaths associated with paracervical block anesthesia. Am J Obstet Gynecol. 1974 Apr 15;118(8):1142-3.</citation>
    <PMID>4817653</PMID>
  </reference>
  <reference>
    <citation>Blanco LJ, Reid PR, King TM. Plasma lidocaine levels following paracervical infiltration for aspiration abortion. Obstet Gynecol. 1982 Oct;60(4):506-8.</citation>
    <PMID>7121936</PMID>
  </reference>
  <reference>
    <citation>Cetin A, Cetin M. Effect of deep injections of local anesthetics and basal dilatation of cervix in management of pain during legal abortions. A randomized, controlled study. Contraception. 1997 Aug;56(2):85-7.</citation>
    <PMID>9315416</PMID>
  </reference>
  <reference>
    <citation>Donati S, Medda E, Proietti S, Rizzo L, Spinelli A, Subrizi D, Grandolfo ME. Reducing pain of first trimester abortion under local anaesthesia. Eur J Obstet Gynecol Reprod Biol. 1996 Dec 27;70(2):145-9.</citation>
    <PMID>9119094</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT. Intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2004 Jun;103(6):1267-72.</citation>
    <PMID>15172863</PMID>
  </reference>
  <reference>
    <citation>Edelman A, Nichols MD, Leclair C, Jensen JT. Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions. Obstet Gynecol. 2006 Feb;107(2 Pt 1):269-75.</citation>
    <PMID>16449111</PMID>
  </reference>
  <reference>
    <citation>Glantz JC, Shomento S. Comparison of paracervical block techniques during first trimester pregnancy termination. Int J Gynaecol Obstet. 2001 Feb;72(2):171-8.</citation>
    <PMID>11166751</PMID>
  </reference>
  <reference>
    <citation>GÃ³mez PI, GaitÃ¡n H, Nova C, Paradas A. Paracervical block in incomplete abortion using manual vacuum aspiration: randomized clinical trial. Obstet Gynecol. 2004 May;103(5 Pt 1):943-51. Review.</citation>
    <PMID>15121569</PMID>
  </reference>
  <reference>
    <citation>Grimes DA, Cates W Jr. Deaths from paracervical anesthesia used for first-trimester abortion, 1972-1975. N Engl J Med. 1976 Dec 16;295(25):1397-9.</citation>
    <PMID>980095</PMID>
  </reference>
  <reference>
    <citation>Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990 Jul;76(1):129-35.</citation>
    <PMID>2359559</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14.</citation>
    <PMID>14622683</PMID>
  </reference>
  <reference>
    <citation>Kan AS, Caves N, Wong SY, Ng EH, Ho PC. A double-blind, randomized controlled trial on the use of a 50:50 mixture of nitrous oxide/oxygen in pain relief during suction evacuation for the first trimester pregnancy termination. Hum Reprod. 2006 Oct;21(10):2606-11. Epub 2006 Jun 21.</citation>
    <PMID>16790607</PMID>
  </reference>
  <reference>
    <citation>Kan AS, Ng EH, Ho PC. The role and comparison of two techniques of paracervical block for pain relief during suction evacuation for first-trimester pregnancy termination. Contraception. 2004 Aug;70(2):159-63.</citation>
    <PMID>15288222</PMID>
  </reference>
  <reference>
    <citation>LÃ³pez JC, Vigil-De Gracia P, Vega-Malek JC, Ruiz E, Vergara V. A randomized comparison of different methods of analgesia in abortion using manual vacuum aspiration. Int J Gynaecol Obstet. 2007 Nov;99(2):91-4. Epub 2007 Jul 12.</citation>
    <PMID>17628562</PMID>
  </reference>
  <reference>
    <citation>Miller L, Jensen MP, Stenchever MA. A double-blind randomized comparison of lidocaine and saline for cervical anesthesia. Obstet Gynecol. 1996 Apr;87(4):600-4.</citation>
    <PMID>8602315</PMID>
  </reference>
  <reference>
    <citation>Nichols, M. D., Halvorson-Boyd, G., Goldstein, R., Gevirtz, C., &amp; Healow, D. (2009). Pain management. In M. Paul, E. S. Lichtenberg, L. Borgatta, D. A. Grimes &amp; P. G. Stubblefield (Eds.), Management of unintended and abnormal pregnancy. (pp. 90-110): Wiley-Blackwell.</citation>
  </reference>
  <reference>
    <citation>O'Connell K, Jones HE, Simon M, Saporta V, Paul M, Lichtenberg ES; National Abortion Federation Members. First-trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2009 May;79(5):385-92. doi: 10.1016/j.contraception.2008.11.005. Epub 2008 Dec 11.</citation>
    <PMID>19341852</PMID>
  </reference>
  <reference>
    <citation>Owolabi OT, Moodley J. A randomized trial of pain relief in termination of pregnancy in South Africa. Trop Doct. 2005 Jul;35(3):136-9.</citation>
    <PMID>16105333</PMID>
  </reference>
  <reference>
    <citation>Phair N, Jensen JT, Nichols MD. Paracervical block and elective abortion: the effect on pain of waiting between injection and procedure. Am J Obstet Gynecol. 2002 Jun;186(6):1304-7.</citation>
    <PMID>12066113</PMID>
  </reference>
  <reference>
    <citation>Rabin JM, Spitzer M, Dwyer AT, Kaiser IH. Topical anesthesia for gynecologic procedures. Obstet Gynecol. 1989 Jun;73(6):1040-4.</citation>
    <PMID>2657523</PMID>
  </reference>
  <reference>
    <citation>Renner RM, Jensen JT, Nichols MD, Edelman A. Pain control in first trimester surgical abortion. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006712. doi: 10.1002/14651858.CD006712.pub2. Review.</citation>
    <PMID>19370649</PMID>
  </reference>
  <reference>
    <citation>Rowbotham MC. What is a &quot;clinically meaningful&quot; reduction in pain? Pain. 2001 Nov;94(2):131-2. Review.</citation>
    <PMID>11690725</PMID>
  </reference>
  <reference>
    <citation>Smith GM, Stubblefield PG, Chirchirillo L, McCarthy MJ. Pain of first-trimester abortion: its quantification and relations with other variables. Am J Obstet Gynecol. 1979 Mar 1;133(5):489-98.</citation>
    <PMID>443287</PMID>
  </reference>
  <reference>
    <citation>Strauss LT, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S; Centers for Disease Control and Prevention (CDC). Abortion surveillance--United States, 2004. MMWR Surveill Summ. 2007 Nov 23;56(9):1-33.</citation>
    <PMID>18030283</PMID>
  </reference>
  <reference>
    <citation>Suprapto K, Reed S. Naproxen sodium for pain relief in first-trimester abortion. Am J Obstet Gynecol. 1984 Dec 15;150(8):1000-1.</citation>
    <PMID>6507524</PMID>
  </reference>
  <reference>
    <citation>Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996 Apr;27(4):485-9.</citation>
    <PMID>8604867</PMID>
  </reference>
  <reference>
    <citation>WHO. (2003). Safe abortion:Technical and policy guidance for health systems</citation>
  </reference>
  <reference>
    <citation>Wiebe E, Podhradsky L, Dijak V. The effect of lorazepam on pain and anxiety in abortion. Contraception. 2003 Mar;67(3):219-21.</citation>
    <PMID>12618257</PMID>
  </reference>
  <reference>
    <citation>Wiebe ER. Comparison of the efficacy of different local anesthetics and techniques of local anesthesia in therapeutic abortions. Am J Obstet Gynecol. 1992 Jul;167(1):131-4.</citation>
    <PMID>1442914</PMID>
  </reference>
  <reference>
    <citation>Wiebe ER, Rawling M. Pain control in abortion. Int J Gynaecol Obstet. 1995 Jul;50(1):41-6.</citation>
    <PMID>7556858</PMID>
  </reference>
  <reference>
    <citation>Zullo F, Pellicano M, Stigliano CM, Di Carlo C, Fabrizio A, Nappi C. Topical anesthesia for office hysteroscopy. A prospective, randomized study comparing two modalities. J Reprod Med. 1999 Oct;44(10):865-9.</citation>
    <PMID>10554747</PMID>
  </reference>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>March 25, 2011</last_update_submitted>
  <last_update_submitted_qc>March 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2011</last_update_posted>
  <responsible_party>
    <name_title>Regina Maria Renner, MD</name_title>
    <organization>Oregon Health and Sciences University</organization>
  </responsible_party>
  <keyword>Paracervical Block</keyword>
  <keyword>pain control</keyword>
  <keyword>abortion</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

